These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 14320599)

  • 1. [OBSERVATIONS ON THE ACTIVE PRINCIPLES OF THE HAGEMAN FACTOR (FACTOR XII)].
    HAANEN C; SCHOENMAKERS JG
    Ned Tijdschr Geneeskd; 1965 Jun; 109():1174-5. PubMed ID: 14320599
    [No Abstract]   [Full Text] [Related]  

  • 2. [DURATION OF LIFE OF THE HAGEMAN FACTOR (FACTOR XII)].
    JOSSO F; PROU-WARTELLE O; CHARLAS J
    Nouv Rev Fr Hematol; 1964; 4():454-6. PubMed ID: 14186229
    [No Abstract]   [Full Text] [Related]  

  • 3. THE INFLAMMATORY PROCESS IN ACUTE GOUTY ARTHRITIS. I. ACTIVATION OF HAGEMAN FACTOR BY SODIUM URATE CRYSTALS.
    KELLERMEYER RW; BRECKENRIDGE RT
    J Lab Clin Med; 1965 Feb; 65():307-15. PubMed ID: 14267254
    [No Abstract]   [Full Text] [Related]  

  • 4. [LIVER AND BLOOD COAGULATION. I. BEHAVIOR OF FACTOR XII (HAGEMAN), OF FACTOR X (STUART) AND OF FIBRINOGEN IN LIVER PATIENTS].
    BOLANDRINA E; SOARDI F
    Gazz Int Med Chir; 1964 Jan; 68():63-79. PubMed ID: 14123792
    [No Abstract]   [Full Text] [Related]  

  • 5. PATHOGENESIS OF INFLAMMATION. II. IN VIVO OBSERVATIONS OF THE INFLAMMATORY EFFECTS OF ACTIVATED HAGEMAN FACTOR AND BRADYKININ.
    GRAHAM RC; EBERT RH; RATNOFF OD; MOSES JM
    J Exp Med; 1965 May; 121(5):807-18. PubMed ID: 14278232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ACTIVATION OF HAGEMAN FACTOR (FACTOR XII) BY LONG-CHAIN SATURATED FATTY ACIDS.
    DIDISHEIM P; MIBASHAN RS
    Thromb Diath Haemorrh; 1963 Jul; 143():346-53. PubMed ID: 14081258
    [No Abstract]   [Full Text] [Related]  

  • 7. ACTIVATION OF HAGEMAN FACTOR (FACTOR XII) BY LONG-CHAIN SATURATED FATTY ACIDS.
    DIDISHEIM P; MIBASHAN RS
    Thromb Diath Haemorrh; 1963 Jul; 33():346-53. PubMed ID: 14085152
    [No Abstract]   [Full Text] [Related]  

  • 8. [HAGEMAN FACTOR DEFICIENCY].
    VERRASTRO T; COSTA MF; JAMRA M
    Rev Hosp Clin Fac Med Sao Paulo; 1963; 18():511-6. PubMed ID: 14119075
    [No Abstract]   [Full Text] [Related]  

  • 9. The purification of activated Hageman factor (activated factor XII).
    RATNOFF OD; DAVIE EW
    Biochemistry; 1962 Nov; 1():967-75. PubMed ID: 13973274
    [No Abstract]   [Full Text] [Related]  

  • 10. The activation of PTA (factor XI) and Hageman factor (factor XII).
    Ratnoff OD; Botti RE; Crum JD; Donaldson VH
    Thromb Diath Haemorrh Suppl; 1965; 17():1-14. PubMed ID: 5335359
    [No Abstract]   [Full Text] [Related]  

  • 11. SURFACE FACTOR MECHANISMS IN RELATION TO BLOOD PLATELETS: EVIDENCE THAT ACTIVATED HAGEMAN FACTOR IS PRESENT ON THE SURFACE OF PLATELETS.
    IATRIDIS PG; FERGUSON JH; IATRIDIS SG
    Thromb Diath Haemorrh; 1964 Jul; 11():355-71. PubMed ID: 14194111
    [No Abstract]   [Full Text] [Related]  

  • 12. HAGEMAN FACTOR IN THE FIBRINOLYTIC SYSTEM.
    AZNAR J; LOPEZ-BORRASCA A
    Lancet; 1965 Feb; 1(7382):437-8. PubMed ID: 14238112
    [No Abstract]   [Full Text] [Related]  

  • 13. Hageman factor.
    ASTRUP T
    Thromb Diath Haemorrh; 1961; 6(Suppl 1)():373-5. PubMed ID: 13965312
    [No Abstract]   [Full Text] [Related]  

  • 14. Activation of factors XII (Hageman) and XI (PTA) by skin contact.
    Nossel HL
    Proc Soc Exp Biol Med; 1966 May; 122(1):16-7. PubMed ID: 5944866
    [No Abstract]   [Full Text] [Related]  

  • 15. Hepatocytes express blood coagulation factor XII (Hageman factor).
    Gordon EM; Gallagher CA; Johnson TR; Blossey BK; Ilan J
    J Lab Clin Med; 1990 Apr; 115(4):463-9. PubMed ID: 2324612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A two-stage assay method for Hageman factor activity.
    IATRIDIS SG; FERGUSON JH
    Thromb Diath Haemorrh; 1962 Oct; 8():46-55. PubMed ID: 13956120
    [No Abstract]   [Full Text] [Related]  

  • 17. The current status of knowledge about Hageman factor.
    RATNOFF OD; DAVIE EW; MALLETT DL
    Thromb Diath Haemorrh; 1961; 6(Suppl 1)():364-71. PubMed ID: 13973275
    [No Abstract]   [Full Text] [Related]  

  • 18. FIBRINOLYTIC ACTIVITY OF THE HAGEMAN FACTOR.
    AZNAR J; SANTIAGO E; MACARULLA JM
    Rev Esp Fisiol; 1964 Sep; 20():101-7. PubMed ID: 14224432
    [No Abstract]   [Full Text] [Related]  

  • 19. The assay of a plasma component necessary for the generation of a plasminogen activator in the presence of Hageman factor (Hageman factor co-factor).
    Ogston D; Bennett NB; Ogston CM; Ratnoff OD
    Br J Haematol; 1971 Feb; 20(2):209-16. PubMed ID: 5548486
    [No Abstract]   [Full Text] [Related]  

  • 20. [Fibrinolytic properties of the Hageman factor. (Thromboelastographical study)].
    AZNAR J; LOPEZ BORRASCA A; CALATAYUD R; BARATA JJ
    Rev Clin Esp; 1963 Jun; 89():276-81. PubMed ID: 13965764
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.